A triple-therapy combination inhaler for moderate to very severe COPD

Description

In this Product Explainer, Prof Christine Jenkins, Head of the Respiratory Group at The George Institute for Global Health; and Senior Staff Specialist in Thoracic Medicine at Concord Hospital explains the role of a triple-therapy combination, pressurised meter dose inhaler for adults with moderate to very severe COPD. (4 mins).

Prof Christine Jenkins

expert

Prof Christine Jenkins

Respiratory Physician; Head, Respiratory Group, The George Institute for Global Health

Date published: 24 January 2022